These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 34771150)

  • 21. Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Chen SY; Hsu YH; Wang SY; Chen YY; Hong CJ; Yen GC
    Phytother Res; 2022 Apr; 36(4):1664-1677. PubMed ID: 35224793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer.
    Kato H; Naiki-Ito A; Suzuki S; Inaguma S; Komura M; Nakao K; Naiki T; Kachi K; Kato A; Matsuo Y; Takahashi S
    Carcinogenesis; 2021 Jul; 42(7):940-950. PubMed ID: 33640964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interlacing anticancer effect of pharmacologic ascorbate, chloroquine, and resveratrol.
    Makk-Merczel K; Varga D; Hajdinák P; Szarka A
    Biofactors; 2024; 50(5):980-996. PubMed ID: 38488303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
    Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.
    Long KB; Tooker G; Tooker E; Luque SL; Lee JW; Pan X; Beatty GL
    Mol Cancer Ther; 2017 Sep; 16(9):1898-1908. PubMed ID: 28611107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.
    Lan CY; Chen SY; Kuo CW; Lu CC; Yen GC
    J Food Drug Anal; 2019 Oct; 27(4):887-896. PubMed ID: 31590760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-nitro-thiophene-thiosemicarbazone derivative induces cell death, cell cycle arrest, and phospho-kinase shutdown in pancreatic ductal adenocarcinoma cells.
    Costa VCMD; Lima MDCA; da Cruz Filho IJ; Galdino LV; Pereira MC; Silva BO; Albuquerque APB; da Rosa MM; Pitta MGDR; Rêgo MJBM
    Eur J Pharmacol; 2024 Nov; 983():176963. PubMed ID: 39260813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells.
    Burmi RS; Maginn EN; Gabra H; Stronach EA; Wasan HS
    Cancer Biol Ther; 2019; 20(1):21-30. PubMed ID: 30261145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
    Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calix[6]arene bypasses human pancreatic cancer aggressiveness: downregulation of receptor tyrosine kinases and induction of cell death by reticulum stress and autophagy.
    Pelizzaro-Rocha KJ; de Jesus MB; Ruela-de-Sousa RR; Nakamura CV; Reis FS; de Fátima A; Ferreira-Halder CV
    Biochim Biophys Acta; 2013 Dec; 1833(12):2856-2865. PubMed ID: 23872419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma.
    Yang W; Meng L; Chen K; Tian C; Peng B; Zhong L; Zhang C; Yang X; Zou J; Yang S; Li L
    Cancer Sci; 2019 Apr; 110(4):1408-1419. PubMed ID: 30618127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs.
    Hashimoto D; Bläuer M; Hirota M; Ikonen NH; Sand J; Laukkarinen J
    Eur J Cancer; 2014 May; 50(7):1382-90. PubMed ID: 24503026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The advanced glycation end-product N
    Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
    J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy.
    Arumugam T; Ramachandran V; Sun D; Peng Z; Pal A; Maxwell DS; Bornmann WG; Logsdon CD
    Mol Cancer Ther; 2013 May; 12(5):654-62. PubMed ID: 23303403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
    Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
    Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pterostilbene inhibits pancreatic cancer in vitro.
    Mannal PW; Alosi JA; Schneider JG; McDonald DE; McFadden DW
    J Gastrointest Surg; 2010 May; 14(5):873-9. PubMed ID: 20140535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.
    Zhu H; Xiao Y; Guo H; Guo Y; Huang Y; Shan Y; Bai Y; Lin X; Lu H
    Aging (Albany NY); 2021 Dec; 13(23):25089-25105. PubMed ID: 34863080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.